Bal Pharma Limited (BOM:524824)
India · Delayed Price · Currency is INR 86.86
+0.85 (0.99%)
At close: Aug 21, 2026
Bal Pharma Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,341 | 3,117 | 3,031 | 3,392 | 3,042 | 2,812 |
Revenue Growth | 13.42% | 2.83% | -10.65% | 11.51% | 8.18% | 12.25% |
Gross Profit Gross Profit Growth | 1,585 | 1,537 | 1,399 | 1,418 | 1,260 | 1,091 |
Operating Income Operating Income Growth | 221.66 | 208.24 | 200.22 | 216.36 | 174.24 | 149.31 |
Net Income Net Income Growth | 72.07 | 62.84 | 72.15 | 73.92 | 25.72 | 56.12 |
Earnings Per Share EPS Growth | 4.50 | 3.95 | 4.55 | 4.70 | 1.64 | 3.79 |
EPS Growth | -1.66% | -13.21% | -3.11% | 186.59% | -56.71% | 13.36% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Unallocated Unallocated Growth | 88.1 | 128.75 | 24.72 | 13.36 |
India India Growth | 1,104 | 1,167 | 924.33 | 847.73 |
Exports Exports Growth | 1,832 | 2,089 | 2,082 | 1,941 |
Total Total Growth | 3,025 | 3,385 | 3,031 | 2,802 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 92.92 | 92.92 | 104.1 | 199.29 | 74.63 | 58.43 |
Total Debt Total Debt Growth | 1,595 | 1,595 | 1,523 | 1,423 | 1,331 | 1,067 |
Net Cash (Debt) Net Cash Growth | -1,502 | -1,502 | -1,419 | -1,223 | -1,256 | -1,008 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -93.85 | -94.43 | -89.51 | -77.73 | -80.06 | -68.02 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 304.43 | 203.15 | 228.06 | -15.37 | 267.96 |
Capital Expenditures CapEx Growth | - | -185.55 | -187.87 | -109.8 | -146.45 | -84.69 |
Free Cash Flow Free Cash Flow Growth | - | 118.88 | 15.28 | 118.26 | -161.83 | 183.26 |
Free Cash Flow Growth | - | 677.91% | -87.08% | - | - | -3.40% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 47.45% | 49.31% | 46.16% | 41.81% | 41.43% | 38.78% |
Operating Margin | 6.63% | 6.68% | 6.61% | 6.38% | 5.73% | 5.31% |
Pretax Margin | 2.05% | 1.90% | 1.70% | 2.67% | 1.56% | 3.27% |
Profit Margin | 2.16% | 2.02% | 2.38% | 2.18% | 0.84% | 1.99% |
FCF Margin | - | 3.81% | 0.50% | 3.49% | -5.32% | 6.52% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.200 | 1.200 | 1.200 | 1.200 | 1.000 | 1.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 20.00% | 0% | 0% |
Dividend Yield | 1.40% | 1.99% | 1.46% | 1.34% | 1.54% | 0.97% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 19.29 | 15.24 | 18.22 | 19.37 | 40.83 | 28.49 |
P/FCF Ratio | 11.63 | 8.05 | 86.00 | 12.11 | - | 8.72 |
PS Ratio | 0.41 | 0.31 | 0.43 | 0.42 | 0.35 | 0.57 |